<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges</h2>
    <div class="badge">2025-09-08T04:35:36+00:00</div>
    <ul>
      <li>- Customers postponed purchases of its products and services this cycle as its revenue declined by 1.2% annually over the last two years - Smaller revenue base of $2.31 billion means it hasn’t achieved the economies of s</li>
<li>- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&amp;A to catalyze faster growth - Competitive supply chain dynamics and steep production costs are</li>
<li>- Annual revenue growth of 22.6% over the past two years was outstanding, reflecting market share gains this cycle - Performance over the past five years shows its incremental sales were more profitable, as its annual ea</li>
<li>Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.</li>
<li>Two Mid-Cap Stocks to Sell: Ball (BALL) Market Cap: $13.86 billion Started with a $200 loan in 1880, Ball (NYSE:BLL) manufactures aluminum packaging for beverages, personal care, and household products as well as aerospa</li>
<li>Royalty Pharma (RPRX) Market Cap: $15.59 billion Pioneering a unique business model in the pharmaceutical industry since 1996, Royalty Pharma (NASDAQ:RPRX) acquires rights to receive portions of sales from successful bio</li>
<li>One Mid-Cap Stock to Buy: LPL Financial (LPLA) Market Cap: $26.64 billion As the nation&#x27;s largest independent broker-dealer with no proprietary products of its own, LPL Financial (NASDAQ:LPLA) provides technology, compli</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges\n• - Customers postponed purchases of its products and services this cycle as its revenue declined by 1.2% annually over the last two years - Smaller revenue base of $2.31 billion means it hasn’t achieved the economies of s\n• - Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&amp;A to catalyze faster growth - Competitive supply chain dynamics and steep production costs are\n• - Annual revenue growth of 22.6% over the past two years was outstanding, reflecting market share gains this cycle - Performance over the past five years shows its incremental sales were more profitable, as its annual ea\n• Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.\n• Two Mid-Cap Stocks to Sell: Ball (BALL) Market Cap: $13.86 billion Started with a $200 loan in 1880, Ball (NYSE:BLL) manufactures aluminum packaging for beverages, personal care, and household products as well as aerospa\n• Royalty Pharma (RPRX) Market Cap: $15.59 billion Pioneering a unique business model in the pharmaceutical industry since 1996, Royalty Pharma (NASDAQ:RPRX) acquires rights to receive portions of sales from successful bio\n• One Mid-Cap Stock to Buy: LPL Financial (LPLA) Market Cap: $26.64 billion As the nation&#x27;s largest independent broker-dealer with no proprietary products of its own, LPL Financial (NASDAQ:LPLA) provides technology, compli" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/1-mid-cap-stock-exciting-043536297.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>